lifestyle.marketresearchjournals.com

Author: Tiberend Strategic Advisors, Inc.

Elysium Therapeutics Raises $7.5 Million SAFE Round to Accelerate Development of Novel Rescue Therapy Designed to Specifically Combat Oral Fentanyl Overdose

January 28, 2026
/C O R R E C T I O N — BridGene Biosciences/

January 27, 2026
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

January 7, 2026
BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board

January 5, 2026
Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

December 30, 2025